Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new polyvalent pseudomonas vaccine.

P Merle, L Robbel, K D Hungerer

    Behring Institute Mitteilungen
    |November 1, 1984
    PubMed
    Summary

    A new Pseudomonas aeruginosa vaccine, using extracts from 24 serotypes, demonstrated protection in mouse studies. This vaccine, composed of lipopolysaccharides and outer membrane proteins, shows promise for preventing Pseudomonas aeruginosa infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study.

    ESMO gastrointestinal oncology·2026
    Same author

    Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French genomic medicine initiative.

    Journal of hepatology·2026
    Same author

    Short-term follow-up of anti-MAG neuropathy patients given bendamustine plus rituximab combination therapy.

    Revue neurologique·2025
    Same author

    Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma.

    ESMO open·2025
    Same author

    Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice.

    Techniques in coloproctology·2024
    Same author

    Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen.

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023

    Area of Science:

    • Microbiology
    • Immunology
    • Vaccinology

    Background:

    • Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections, particularly in immunocompromised individuals.
    • Existing vaccines for P. aeruginosa are limited, necessitating the development of broader protective strategies.

    Purpose of the Study:

    • To develop and evaluate a novel polyvalent vaccine against Pseudomonas aeruginosa.
    • To assess the protective efficacy of the vaccine in preclinical mouse models.

    Main Methods:

    • A polyvalent vaccine was formulated using extracts from 24 serotypes of P. aeruginosa based on the Lanyi typing scheme.
    • The vaccine's efficacy was tested through passive and active protection studies in mice.
    • Rabbit antiserum against the vaccine was analyzed for protective capacity, including in a leucopenic mouse model.

    Main Results:

    • The vaccine, primarily composed of lipopolysaccharides and outer membrane proteins, conferred protection in both passive and active mouse protection studies.
    • Rabbit antiserum derived from the vaccine exhibited significant protective capacity in its IgG fraction.
    • The antiserum demonstrated protection against 3 out of 6 challenge strains in a leucopenic mouse model, indicating efficacy in an immunocompromised setting.

    Conclusions:

    • The developed polyvalent Pseudomonas aeruginosa vaccine shows significant protective potential.
    • The vaccine's components, lipopolysaccharides and outer membrane proteins, are key contributors to its immunogenicity and protective effects.
    • Further investigation into this vaccine candidate is warranted for its potential clinical application against P. aeruginosa infections.

    Related Experiment Videos